MetriportSummer 2022Active☆Watch⊞Compare

Metriport is one of 2138 Healthtech companies tracked from San Francisco, CA, USA, on record since 2022. By capital raised it ranks in the long tail (ahead of 8% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst”

Open-Source Platform for Healthcare Data Intelligence

Metriport provides real-time access to comprehensive medical data for 300M+ individuals across the US. Our open-source intelligence platform helps organizations access, analyze, and exchange patient data while integrating with all major healthcare IT systems. If you’ve been to doctors in the US, you may have encountered the problem: how does a healthcare provider get access to your up-to-date medical history to treat you properly? Reliance on archaic methods is still the norm: typically, you or your provider need to call the facilities where you’ve previously received treatment (assuming you remember them all), just to have them send your records via fax (yep, fax). This can take weeks, only then to have a provider sift through hundreds of pages of unstructured docs, just to figure out basic things like your active medication list, what conditions you may have, latest lab results, etc. This not only delays care—it can cause improper treatment, since the medical history is critical for informing treatment decisions. Metriport integrates fragmented medical data from thousands of sources—including both national and state/regional Health Information Exchanges (HIEs), ADTs, EHRs, pharmacies, and labs—through a single API connector. The platform then standardizes, deduplicates, and enriches this data to create a comprehensive longitudinal patient record, with AI-powered clinical summaries. Along with a rich understanding of patient health history, healthcare providers also get realtime updates about their patients' health through Metriport. This includes getting notified when a patient is discharged from the hospital, picks up their prescription from the pharmacy, or has a new lab result available. Through this data, care teams get insights across their patient population, helping with 30-day readmissions prediction, care gap closure, risk adjustment, and more. On top of all of this, Metriport enables healthcare organizations to share net-new clinical information back to all major healthcare IT systems, and to become interoperable with popular EHR systems such as Epic, Cerner, athena, eClinicalWorks, and many more—forming an internet for healthcare data. Metriport improves both patient and provider lives at the point-of-care, supporting use cases such as medication adherence, transitions of care management, chart prep, and much more. If you want to do work that matters, get in touch with us today.

As reported in public records reported — not modeled.

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

No round amounts on record to chart.

No staged rounds to sequence.

Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Raised more than 8% of sector peers (real $). Modeled value above 8% of peers (estimate).

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Metriport is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

See where Metriport sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

If you work at Metriport, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.